Restor3d, a company developing 3D-printed orthopaedic implants, has expanded its Kinos Total Ankle System with new personalised, patient-centric implants.
The new addition, the Kinos Range articulating surface, includes materials like vitamin E, highly crosslinked polyethylene, and 3D-printed cobalt chrome.
It helps surgeons check soft tissue health during surgery and customise the resulting articulation for each patient’s needs.
The Kinos Total Ankle System, which includes the Range Talar and Poly components, is the latest upgrade to the Kinos Total Ankle line.
The system provides surgeons with more options during surgery by offering interchangeable articulations.
Surgeons can choose between the Kinos Anatomic tri-planar range of motion or the more controlled Range articulation, depending on the patient’s soft tissue and alignment.
The Range implants offer better stability in the coronal plane and improved biomechanics, while also reducing contact stress compared to older dual condyle implants.
Like the Anatomic predecessor, the Kinos Range is designed to reduce wear during movement using its advanced design compared to older, more restricted total ankle implants.
Restor3d product development senior vice president Brian Garvey said: “The continued advancements within the Kinos Total Ankle System are driven by extensive biomechanics research and our commitment to offering surgeons a market leading portfolio for patient-specific care.
“The intraoperative decision-making capabilities of this system are facilitated by a modular trialing system that enables both articulations to be assessed through the patient’s range of motion while dialing in the placement of the definitive implant.
“Every patient presents with unique factors, and we work to accommodate them all in a personalised manner.”
Restor3d develops 3D-printed implants that are customised for each patient using artificial intelligence (AI).
In addition, the company is expanding in the musculoskeletal reconstruction sector.
In June, the orthopaedic implants maker closed a $55m Series A funding round along with $15m in debt financing.
Prior to that, in January 2024, Restor3d completed the acquisition of Conformis to add femoral implants to its portfolio.
